Product
TAS-205
1 clinical trial
1 indication
Indication
Duchenne muscular dystrophyClinical trial
A Phase 3, Randomized, Placebo-controlled, Double-blind and Open-label, Extension Study of TAS-205 in Patients With Duchenne Muscular DystrophyStatus: Recruiting, Estimated PCD: 2027-05-01